Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2023 08:30 ET | Source: Dyadic International, Inc.

Dyadic to Present at Roth Investor Conference and Upcoming Industry Events

JUPITER, Fla., March 01, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
February 02, 2023 08:30 ET | Source: Dyadic International, Inc.

Dyadic to Participate in Two Upcoming Investor Conferences

JUPITER, Fla., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
September 08, 2022 08:30 ET | Source: Dyadic International, Inc.

Dyadic to Present at Upcoming Industry and Investor Events in September

JUPITER, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
July 27, 2022 16:30 ET | Source: Dyadic International, Inc.

Dyadic to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

JUPITER, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
March 22, 2021 21:00 ET | Source: Dyadic International, Inc.

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...